1-6 of 6
Hang Quach, MBBS (Hons), FRACP, FRCPA, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial

Robert J Pelham, PhD, Xuguang Hu, PhD, Philippe Moreau, MDPhD, Albert Oriol, MD, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Tibor Kovacsovics, Jonathan J Keats, PhD, Shibao Feng, PhD, Amy S. Kimball, Meletios A. Dimopoulos
Journal: Blood
Blood (2017) 130 (Supplement 1): 839.
https://doi.org/10.1182/blood.V130.Suppl_1.839.839
Published: 2017
Journal Articles

An Open-Label, Single-Arm, Phase 1 Study of the Pharmacokinetics (PK) and Safety of Carfilzomib in Patients with Relapsed Multiple Myeloma and End-Stage Renal Disease (ESRD)

Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Darrell White, Andrew Spencer, P. Joy Ho, Divaya Bhutani, Mike White, Sandeep Inamdar, Chris Morris, Ying Ou, Martin Gyger
Journal: Blood
Blood (2016) 128 (22): 3318.
https://doi.org/10.1182/blood.V128.22.3318.3318
Published: 2016
Journal Articles

Improved Survival of Older Patients with Mantle Cell Lymphoma (MCL) with Front-Line Cytarabine-Based Immunochemotherapy

Sumita Ratnasingam, MBBS, Michael Gilbertson, Zoe McQuilten, MBBS, Kay T Htun, George Grigoriadis, MBBS, PhD BSc, Swe Myo Htet, MBBS, Philip Campbell, MBBS, FRACP, FRCPA, Khai Li Chai, MBBS, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Sushrut S. Patil, FRACP, FRCPA, Jake Shortt, MD, Stephen Opat, MD
Journal: Blood
Blood (2016) 128 (22): 2965.
https://doi.org/10.1182/blood.V128.22.2965.2965
Published: 2016
Journal Articles

Intravital Microscopy Reveals Fundamental Differences in the Interaction of Stem Cells and T Acute Lymphoblastic Leukaemia with the Bone Marrow Microenvironment

Cristina Lo Celso, PhD, Edwin D Hawkins, PhD, Delfim Duarte, MD, Olufolake Akinduro, PhD, Reema A Khorshed, PhD, Diana Passaro, PhD, Malgorzata Nowicka, Lenny Straszkowski, Mark K Scott, Steve Rothery, Nicola Ruivo, Katie Foster, Michaela Waibel, Ricky W Johnstone, PhD, Simon J. Harrison, David A Westerman, MBBS, FRACP, FRCPA, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, John Gribben, Mark D Robinson, Louise E Purton, PhD, Dominique Bonnet, PhD
Journal: Blood
Blood (2016) 128 (22): 5199.
https://doi.org/10.1182/blood.V128.22.5199.5199
Published: 2016
Journal Articles

A 2-Stage Phase II Study of Panobinostat Consolidation in Multiple Myeloma (MM) Patients with < CR Following Single High-Dose Chemotherapy (HDT) Conditioned Autologous Stem Cell Transplantation (ASCT) As Part of First Line Therapy

Anna Kalff, MBBS, FRACP, FRCPA, Sridurga Mithraprabhu, PhD, Tiffany T. Khong, PhD, Malarmathy Ramachandran, Kate Reed, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Patricia A. Walker, MBBS, FRACP, FRCPA, Krystal Bergin, Andrew Spencer
Journal: Blood
Blood (2016) 128 (22): 4515.
https://doi.org/10.1182/blood.V128.22.4515.4515
Published: 2016
Journal Articles

Daratumumab, Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy Analysis of Castor

Asher A. Chanan-Khan, MD, Suzanne Lentzsch, MD PhD, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Noemi Horvath, MB, ChB, FRACP, FRCPA, Marcelo Capra, MD PhD, Roberto Ovilla, MD PhD, Jae-Cheol Jo, MD PhD, Ho-Jin Shin, MD PhD, Ming Qi, William Deraedt, Jordan Schecter, Himal Amin, Xiang Qin, Tineke Casneuf, Christopher Chiu, A. Kate Sasser, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3313.
https://doi.org/10.1182/blood.V128.22.3313.3313
Published: 2016